XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
The following table summarizes our common share repurchases and issuances.

 
Three Months Ended 
 June 30,		Six Months Ended 
 June 30,

(Shares and per share amounts in actuals)		2023202220232022
Common stock repurchased under repurchase programs(1)
16,389,696 19,997,008 16,389,696 29,530,400 
Average purchase price per share(2)
$15.71 $18.01 $15.71 $18.15 
Shares repurchased related to employee stock-based compensation plans(3)
128,212 196,301 1,077,643 1,130,903 
Average purchase price per share$14.64 $17.45 $15.44 $18.36 
Common shares issued(4)
349,009 493,893 2,872,753 3,088,710 
 
(1) Common shares purchased under our share repurchase programs. We have utilized all capacity under our 2021 Share Repurchase Program. There was $326 million of capacity remaining under the 2022 Share Repurchase Program at June 30, 2023.
(2) Average purchase price per share includes purchase commission costs and excise taxes.
(3) Comprised of shares withheld from stock option exercises and vesting of restricted stock for employees’ tax withholding obligations and shares tendered by employees to satisfy option exercise costs.
(4)  Common shares issued under our various compensation and benefit plans.
 
The closing price of our common stock on the NASDAQ Global Select Market on June 30, 2023 was $16.32.

Common Stock Dividends

In both June 2023 and June 2022, we paid a common stock dividend of $0.11 per common share.

Share Repurchases
On January 27, 2021, we announced a share repurchase program (the “2021 Share Repurchase Program”), which was effective upon announcement and expired on January 26, 2023, and originally permitted us to repurchase shares of our common stock from time to time up to an aggregate repurchase price not to exceed $1.25 billion.
In October 2021, our Board of Directors approved a $250 million increase in the amount of common stock that may be repurchased under our 2021 Share Repurchase Program. This was in addition to the original $1.25 billion of authorization announced on January 27, 2021, for a total 2021 Share Repurchase Program authorization of $1.5 billion. Under the 2021 Share Repurchase Program, we repurchased 2.0 million shares of common stock for $38 million in the six months ended June 30, 2022. We have utilized all capacity under the 2021 Share Repurchase Program.
On January 26, 2022, we announced a new share repurchase program (the “2022 Share Repurchase Program”), which was effective upon announcement and expires on January 25, 2024, and permits us to repurchase shares of our common stock from time to time up to an aggregate repurchase price not to exceed $1.25 billion. Under the 2022 Share Repurchase Program, we repurchased 16.4 million shares of common stock for $257 million in both the three and six months ended June 30, 2023. Under the 2022 Share Repurchase Program, we also repurchased 20.0 million shares of common stock for $360 million in the three months ended June 30, 2022, and 27.5 million shares of common stock for $498 million in the six months ended June 30, 2022. We had $326 million of capacity remaining under the 2022 Share Repurchase Program at June 30, 2023.
So long as there is unexpired capacity under a given repurchase program, repurchases under the programs may occur from time to time and through a variety of methods, including tender offers, open market repurchases, repurchases effected through Rule 10b5-1 trading plans, negotiated block purchases, accelerated share repurchase programs, or other similar transactions. The timing and volume of any repurchases under the 2022 Share Repurchase Program will be subject to market conditions, and there can be no guarantee that the Company will repurchase up to the limit of the program or at all.
Share Repurchases under Rule 10b5-1 trading plansDuring the three months ended June 30, 2023 and 2022, we repurchased 16.4 million shares and 20.0 million shares of our common stock at a total cost of $257 million and $360 million, respectively, and during the six months ended June 20, 2023 and 2022, we repurchased 16.4 million and 29.5 million shares, respectively, of our common stock at a total cost of $257 million and $536 million, respectively, under Rule 10b5-1 trading plans authorized under our share repurchase programs.